SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
16 references·0 citing·31 second hop
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)Cost-effectiveness of Interventions to Ma…Economic Costs of Diabetes in the U.S. in 2017 (2018)Economic Costs of Diabetes in…Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis (2010)Delivering the diabetes educa…Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review (2010)Cost-Effectiveness of Interve…Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis (2010)Age at initiation and frequen…Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial (2008)Cost effectiveness of self mo…Cost-Effectiveness and Net Benefit of Enhanced Treatment of Depression for Older Adults With Diabetes and Depression (2006)Cost-Effectiveness and Net Be…Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes (2005)Clinical Outcomes and Cost-Ef…Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Screening for Type 2 Diabetes…Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in…Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-effectiveness of Intensi…Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Cost effectiveness of an inte…Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness analysis o…Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness analysis o…Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Model of Complications of NID…Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Lifetime Benefits and Costs o…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Inductive Teaching and Learning Methods: Definitions, Comparisons, and Research Bases (2006)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Costs, effects and C/E‐ratios alongside a clinical trial (1994)Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. (2002)The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Valuing Health-Related Quality of Life in Diabetes (2002)Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program (2003)The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis (2008)The Lifetime Cost of Diabetes and Its Implications for Diabetes Prevention (2014)Department of Labor (1941)Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications (2013)Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force (2015)Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review (2020)Cost-Effectiveness in Health and Medicine (1996)Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments (2007)Health Care Economic Analyses and Value-Based Medicine (2003)A Bayesian approach to stochastic cost-effectiveness analysis (1999)Definition, interpretation and calculation of cost-effectiveness acceptability curves (2000)Social Determinants of Health and Diabetes: A Scientific Review (2020)Economic Costs of Diabetes in the U.S. in 2022 (2023)The Economic Burden of Racial, Ethnic, and Educational Health Inequities in the US (2023)Economic Costs of Diabetes in the U.S. in 2012 (2013)The State of US Health, 1990-2010 (2013)El coste de la diabetes tipo 2 en España. El estudio CODE-2 (2002)Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72) (2005)
this work references cited by second hop

References

  • 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
  • 2018Economic Costs of Diabetes in the U.S. in 20172,528 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,821 cited
  • 2002Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes507 cited
  • 2010Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review491 cited
  • 1996Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial349 cited
  • 1997Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia333 cited
  • 2000Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)322 cited
  • 2005Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes318 cited
  • 1998Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40302 cited
  • 1998Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40301 cited
  • 2010Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis286 cited
  • 2006

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cost-Effectiveness and Net Benefit of Enhanced Treatment of Depression for Older Adults With Diabetes and Depression
259 cited
  • 2010Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis251 cited
  • 2008Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial206 cited
  • 2004Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis178 cited
  • Cited by

    No citing works inside the corpus for this window.